US Bancorp’s NexImmune, Inc. Common Stock NEXI Stock Holding History

US Bancorp’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5	Closed	-$2K	–	4258
2021 Q3	$2K	Buy	+5	New	+$1.68K	﹤0.01%	3938

Other funds holding NEXI

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Allen Operations New York $670M AUM 26.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

US Bancorp's NEXI Position: Q4 2021 in Review

US Bancorp sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2021, closing a stake of 5 shares — an estimated $2K sold.

US Bancorp first reported a position in NEXI in Q3 2021 and held it in 1 quarter. The position peaked at $2K in Q3 2021. 46 funds tracked by Wall St. Rank hold NEXI as of Q4 2021.

US Bancorp reported no remaining NexImmune, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
US Bancorp sold 5 NexImmune, Inc. Common Stock shares in Q4 2021, an estimated $2K.
US Bancorp first reported a position in NexImmune, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
US Bancorp's NexImmune, Inc. Common Stock position peaked at $2K in Q3 2021.
46 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2021.

Based on US Bancorp's 13F filing for Q4 2021, filed 11 Feb 2022.